| Financial Year |
March 31 2023 |
| Monetary Funds |
1,427,055,059.79 |
| Held-for-trading Financial Assets |
287,777,479.45 |
| Notes Receivable |
563,885,004.55 |
| Accounts Receivable |
1,877,432,506.98 |
| Advances to Suppliers |
265,097,474.76 |
| Other Receivables |
439,313,998.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,258,071,765.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
9,621,903.32 |
| Other Current Assets |
102,597,185.41 |
| Total Current Assets |
6,726,017,707.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
14,402,534.93 |
| Long-term Equity Investment |
15,397,650.15 |
| Investment Properties |
1,665,644.38 |
| Fixed Assetes |
2,433,880,052.16 |
| Under-construction Projects |
273,037,094.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
975,320,113.18 |
| R&D expenses |
193,168,901.27 |
| Goodwill |
421,600,099.03 |
| Long-Term Deferred and Prepaid Expenses |
95,730,743.89 |
| Deferred Income Tax Assets |
130,310,522.52 |
| Other Non-Current Assets |
52,930,948.23 |
| Sub-Total of Non-Current Assets |
4,794,679,806.60 |
| Total Assets |
11,520,697,514.16 |
| Short-Term Loans |
1,606,900,125.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
262,534,321.19 |
| Accounts Payable |
733,170,109.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
52,384,804.61 |
| Taxes Payable |
28,259,895.04 |
| Interest Payable |
-- |
| Dividend Payable |
1,371,654.85 |
| Other payables |
102,678,056.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
837,942,362.16 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
3,891,652,076.32 |
| Long-term Loans |
617,241,989.45 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
9,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
15,090,620.16 |
| Deferred Income Tax Liabilities |
15,174,699.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
909,605,530.01 |
| Total Liabilities |
4,801,257,606.33 |
| Paid-In Capital(Or Share Stock) |
945,425,815.00 |
| Capital Surplus |
3,230,628,556.36 |
| Surplus Reserve |
126,298,268.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,962,370,901.30 |
| Minority Stockholder's Interest |
419,193,627.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,300,246,280.24 |
| Owner's Equity（Stockholder's Equity） |
6,719,439,907.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,520,697,514.16 |
